UK Teenager Achieves Functional Cure for Thalassemia via Gene Editing
A 16-year-old UK patient, Vian, has successfully undergone gene editing to reverse symptoms of thalassemia, eliminating the need for lifelong monthly blood transfusions. The treatment, which involves editing stem cells to produce fetal hemoglobin, is described by clinicians as a 'functional cure.' While Vian has recovered and resumed normal activities, another patient, 14-year-old JoelSamuel, is currently undergoing the same procedure for sickle cell disease, highlighting the therapy’s expanding application in UK children’s hospitals.